Defensins
A family of endogenous antimicrobial peptides forming the first line of innate immune defense.
Overview
Defensins are a family of small (18-45 amino acid) cysteine-rich cationic antimicrobial peptides produced by neutrophils, macrophages, and epithelial cells. They are divided into alpha-defensins (HNP-1 to HNP-4, HD-5, HD-6) and beta-defensins (hBD-1 to hBD-4), each with distinct tissue expression patterns.
The following information summarizes peer-reviewed research on Defensins. Study descriptions reflect published findings, e.g., "animal studies have investigated," "cellular studies suggest," or "clinical trials have evaluated", and do not constitute therapeutic claims.
Mechanism of Action
Defensins form pores in microbial membranes through electrostatic attraction to anionic phospholipids. Beyond direct antimicrobial activity, they recruit and activate immune cells, enhance phagocytosis, and modulate adaptive immune responses by acting as chemoattractants for T-cells and dendritic cells.
Research Evidence
Defensins. Evidence Summary
No peer-reviewed studies have been indexed for this compound
Evidence Level 1: Early Research, Very limited published research. May include only 1–2 preliminary laboratory or theoretical studies.
Study Type Distribution
18
Human Studies
117
Animal Studies
0
In Vitro
65
Reviews
197
Last 5 Years
197
Last 10 Years
41973
Total Indexed Studies
Research Coverage
Last PubMed Ingestion
…
Research Timeline
Chronological progression of Defensins research, auto-generated from 3 indexed publications.
Ganz (2003). Comprehensive review of defensins in innate immunity.
Research on Defensins
Lehrer & Lu (2012). Structural biology and mechanisms of action of alpha-defensins.
Research on Defensins
Semple & Bhatt (2015). Beta-defensins in mucosal immunity and inflammation.
Research on Defensins
Conditions Studied
Research Studies
Ganz, T. Nature Reviews Immunology, 2003
Ganz, T
Nature Reviews Immunology, 2003
Referenced study on Defensins investigating antimicrobial therapy development.
Defensins research — Lehrer, R
Lehrer, R
Immunological Reviews, 2012
Referenced study on Defensins investigating antimicrobial therapy development.
Study Highlights
Study summaries are being curated for Defensins.
Further Reading
Scientific Context
This page summarizes published scientific research on Defensins. Many peptides discussed on this site are experimental research compounds that have not been approved for clinical use. The research presented here is sourced from peer-reviewed journals and indexed databases such as PubMed. Evidence levels and study counts reflect the quantity and type of available research, not efficacy or safety endorsements.
This content is for educational and informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making any health-related decisions.
Learn about our editorial standards →Research Transparency
PSI functions as a transparent research index. All research information is sourced from peer-reviewed scientific literature and automatically indexed from PubMed/MEDLINE. Every study displayed includes verifiable source references. PubMed ID, journal, authors, and publication year, allowing independent verification. PSI does not make therapeutic claims; all content summarizes published research findings.
Looking for a physician who prescribes this peptide? Browse the PSI physician directory →
Published: January 15, 2025
Updated: March 1, 2026
This content is for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Consult a qualified healthcare provider before making any health decisions.